VNRX
Volitionrx LtdCompany with tickers: VNRX
CIK
93314
CUSIP
928661107
Shares Outstanding
8,330,270
13F Activity (30d)
26 filings
26 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $985,076 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $6,333,928 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $2,852,251 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-5,348,852 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-6,664,774 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | — | ||||
| EPS (Diluted) | $-0.97 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |